المؤلفون: Reinert, Jochim, Beitzen-Heineke, Antonia, Wethmar, Klaus, Stelljes, Matthias, Fiedler, Walter, Schwartz, Stefan

المصدر: http://lobid.org/resources/99370678538206441Test#!, 100(11):2727-2732.

مصطلحات موضوعية: B-Lymphocytes/chemistry [MeSH], CD22, Aged, 80 and over [MeSH], Allografts [MeSH], Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy [MeSH], Flow Cytometry [MeSH], Inotuzumab-Ozogamicin, Lymphocyte Subsets/pathology [MeSH], Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/blood [MeSH], Original Article, Lymphocyte Subsets/chemistry [MeSH], Male [MeSH], Clone Cells [MeSH], Immunophenotyping [MeSH], B-ALL, Sialic Acid Binding Ig-like Lectin 2/analysis [MeSH], Female [MeSH], Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology [MeSH], Adult [MeSH], Humans [MeSH], Salvage Therapy [MeSH], Hematopoietic Stem Cell Transplantation [MeSH], Middle Aged [MeSH], Sorafenib/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], B-Lymphocytes/pathology [MeSH], Recurrence [MeSH], Antibodies, Bispecific/therapeutic use [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6447807Test; https://doi.org/10.1007/s00277-021-04601-0Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510963Test/

الإتاحة: https://doi.org/10.1007/s00277-021-04601-0Test
https://repository.publisso.de/resource/frl:6447807Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510963Test/

المؤلفون: Glutsch, Valerie, Kneitz, Hermann, Gesierich, Anja, Goebeler, Matthias, Haferkamp, Sebastian, Becker, Jürgen C., Ugurel, Selma, Schilling, Bastian

المصدر: http://lobid.org/resources/99370671253406441Test#!, 70(7):2087-2093.

مصطلحات موضوعية: Research Report, Aged [MeSH], Merkel cell carcinoma, Antibodies, Monoclonal, Humanized/administration, Skin Neoplasms/drug therapy [MeSH], Ipilimumab/administration, Male [MeSH], Carcinoma, Merkel Cell/drug therapy [MeSH], Ipilimumab, Avelumab, Female [MeSH], Follow-Up Studies [MeSH], Drug Resistance, Neoplasm/drug effects [MeSH], Response Evaluation Criteria in Solid Tumors [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Resistance, Middle Aged [MeSH], Skin Neoplasms/pathology [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Nivolumab, Survival Rate [MeSH], Merkel Cell/pathology [MeSH], Prognosis [MeSH], Nivolumab/administration

العلاقة: https://repository.publisso.de/resource/frl:6451427Test; https://doi.org/10.1007/s00262-020-02832-0Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195807Test/

الإتاحة: https://doi.org/10.1007/s00262-020-02832-0Test
https://repository.publisso.de/resource/frl:6451427Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195807Test/

المؤلفون: Müller, Carolin, Schmidt, Gilda, Juhasz-Böss, Ingolf, Jung, Lisa, Huwer, Sarah, Solomayer, Erich-Franz, Juhasz-Böss, Stephanie

المصدر: http://lobid.org/resources/99370671687406441Test#!, 304(4):1065-1071.

مصطلحات موضوعية: Female [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Breast cancer, Neo-adjuvant therapy, Treatment Outcome [MeSH], Breast Neoplasms/drug therapy [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Neoadjuvant Therapy [MeSH], Chemotherapy, Adjuvant [MeSH], Clinical trials, Disease-Free Survival [MeSH], Young Adult [MeSH], Pathologic complete response, Neoplasm Recurrence, Local [MeSH], Receptor, ErbB-2 [MeSH], Gynecologic Oncology

العلاقة: https://repository.publisso.de/resource/frl:6450592Test; https://doi.org/10.1007/s00404-021-06018-6Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429372Test/

الإتاحة: https://doi.org/10.1007/s00404-021-06018-6Test
https://repository.publisso.de/resource/frl:6450592Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429372Test/

المؤلفون: Hertel, Nadine, Merz, Hartmut, Bernd, Heinz-Wolfram, Bernard, Veronica, Künstner, Axel, Busch, Hauke, von Bubnoff, Nikolas, Feller, Alfred C., WITTE, HANNO, Gebauer, Niklas

المصدر: http://lobid.org/resources/99370674181806441Test#!, 147(10):3043-3050.

مصطلحات موضوعية: Female [MeSH], Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Original Article – Clinical Oncology, Plasmablastic Lymphoma/drug therapy [MeSH], Plasmablastic lymphoma, Humans [MeSH], Plasmablastic Lymphoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Prognosis, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Nomograms [MeSH], Survival Rate [MeSH], International Agencies [MeSH], Male [MeSH], Risk stratification, Prognosis [MeSH], IPI

العلاقة: https://repository.publisso.de/resource/frl:6449902Test; https://doi.org/10.1007/s00432-021-03580-zTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397630Test/

الإتاحة: https://doi.org/10.1007/s00432-021-03580-zTest
https://repository.publisso.de/resource/frl:6449902Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397630Test/

المؤلفون: Susok, L., Stücker, M., Bechara, F. G., Stockfleth, E., Gambichler, Thilo

المصدر: http://lobid.org/resources/99370674181806441Test#!, 147(9):2759-2764.

مصطلحات موضوعية: Aged, 80 and over [MeSH], Aged [MeSH], Original Article – Clinical Oncology, Skin Neoplasms/drug therapy [MeSH], Nodular melanoma, Neoplasm Recurrence, Local/pathology [MeSH], Prognostic, Logistic regression, Lymphatic Metastasis [MeSH], Male [MeSH], Melanoma/pathology [MeSH], Superficial spreading melanoma, Melanoma/drug therapy [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Factors, Adult [MeSH], Humans [MeSH], Skin Neoplasms/classification [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Skin Neoplasms/pathology [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Tumor thickness, Survival Rate [MeSH], Melanoma/classification [MeSH], Prognosis [MeSH], Young Adult [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6449918Test; https://doi.org/10.1007/s00432-021-03562-1Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310843Test/

الإتاحة: https://doi.org/10.1007/s00432-021-03562-1Test
https://repository.publisso.de/resource/frl:6449918Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310843Test/

المؤلفون: Noepel-Duennebacke, Stefanie, Juette, Hendrik, Schulmann, Karsten, Graeven, Ulrich, Porschen, Rainer, Stoehlmacher, Jan, Hegewisch-Becker, Susanna, Raulf, Arne, Arnold, Dirk, Reinacher-Schick, Anke, Tannapfel, Aandrea

المصدر: http://lobid.org/resources/99370674181806441Test#!, 147(10):3063-3072.

مصطلحات موضوعية: PD-L1, Original Article – Clinical Oncology, Microsatellite instability, Clinical Trials, Phase III as Topic [MeSH], B7-H1 Antigen/metabolism [MeSH], Colorectal Neoplasms/metabolism [MeSH], Bevacizumab/administration, Randomized Controlled Trials as Topic [MeSH], Male [MeSH], Metastatic colorectal cancer, Colorectal Neoplasms/immunology [MeSH], Biomarkers, Tumor/analysis [MeSH], Fluorouracil/administration, Oxaliplatin/administration, Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Colorectal Neoplasms/drug therapy [MeSH], Overall survival, Retrospective Studies [MeSH], Middle Aged [MeSH], Neoplasm Invasiveness [MeSH], Microsatellite Instability [MeSH], Bevacizumab, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Immunoscore, Prognosis [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6449914Test; https://doi.org/10.1007/s00432-021-03559-wTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397637Test/

الإتاحة: https://doi.org/10.1007/s00432-021-03559-wTest
https://repository.publisso.de/resource/frl:6449914Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397637Test/

المؤلفون: Morkramer, Lisa, Geitner, Maren, Boeger, Daniel, Buentzel, Jens, Kaftan, Holger, Mueller, Andreas H., Ernst, Thomas, Guntinas-Lichius, Orlando

المصدر: http://lobid.org/resources/99370674181806441Test#!, 147(9):2625-2635.

مصطلحات موضوعية: Palliative immunotherapy, Aged, 80 and over [MeSH], Aged [MeSH], Original Article – Clinical Oncology, Palliative chemotherapy, Squamous Cell Carcinoma of Head and Neck/epidemiology [MeSH], Metastatic disease, Neoplasm Recurrence, Local/pathology [MeSH], Germany/epidemiology [MeSH], Male [MeSH], Carcinoma, Head and Neck Neoplasms/epidemiology [MeSH], Recurrent disease, Female [MeSH], Follow-Up Studies [MeSH], Adult [MeSH], Head and neck, Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Squamous Cell Carcinoma of Head and Neck/drug therapy [MeSH], Squamous Cell Carcinoma of Head and Neck/secondary [MeSH], Head and Neck Neoplasms/drug therapy [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Health Services Research/statistics, Prognosis [MeSH], Local/drug therapy [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6449922Test; https://doi.org/10.1007/s00432-021-03535-4Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310840Test/

الإتاحة: https://doi.org/10.1007/s00432-021-03535-4Test
https://repository.publisso.de/resource/frl:6449922Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310840Test/

المؤلفون: Steinhardt, Maximilian Johannes, Krummenast, Franziska C., Rosenwald, Andreas, Gerhard-Hartmann, Elena, Heidemeier, Anke, Einsele, Hermann, Topp, Max S., Duell, Johannes

المصدر: http://lobid.org/resources/99370674181806441Test#!, 148(1):205-214.

مصطلحات موضوعية: HD, Lymphoma, Aged [MeSH], Prednisone/adverse effects [MeSH], Original Article – Clinical Oncology, Cytarabine/therapeutic use [MeSH], Progression-Free Survival [MeSH], Cyclophosphamide/therapeutic use [MeSH], Cyclophosphamide/adverse effects [MeSH], Rituximab/therapeutic use [MeSH], Male [MeSH], Central Nervous System Neoplasms/drug therapy [MeSH], Prednisone/therapeutic use [MeSH], Female [MeSH], Carmustine/therapeutic use [MeSH], Doxorubicin/adverse effects [MeSH], Large B-Cell, Diffuse/drug therapy [MeSH], Adult [MeSH], R-CHOP, Humans [MeSH], Hematopoietic Stem Cell Transplantation [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], MTX, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Vincristine/therapeutic use [MeSH], Methotrexate/therapeutic use [MeSH], Doxorubicin/therapeutic use [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6449866Test; https://doi.org/10.1007/s00432-021-03663-xTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752544Test/

الإتاحة: https://doi.org/10.1007/s00432-021-03663-xTest
https://repository.publisso.de/resource/frl:6449866Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752544Test/

المؤلفون: Lordick, Florian, Al-Batran, Salah-Eddin, Ganguli, Arijit, Morlock, Robert, Sahin, Ugur, Türeci, Özlem

المصدر: http://lobid.org/resources/99370673525306441Test#!, 24(3):721-730.

مصطلحات موضوعية: Surveys and Questionnaires [MeSH], Biomarkers, Antibodies, Monoclonal/therapeutic use [MeSH], Epirubicin/therapeutic use [MeSH], Progression-Free Survival [MeSH], Oxaliplatin/therapeutic use [MeSH], Esophageal Neoplasms/pathology [MeSH], Esophageal Neoplasms/drug therapy [MeSH], Original Article, Adenocarcinoma/secondary [MeSH], Male [MeSH], Stomach Neoplasms/secondary [MeSH], Adenocarcinoma/drug therapy [MeSH], Stomach Neoplasms/drug therapy [MeSH], Female [MeSH], Capecitabine/therapeutic use [MeSH], Patient-reported outcomes, Monoclonal, Humans [MeSH], Neoplasm Metastasis [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Patient Reported Outcome Measures [MeSH], Stomach cancer, Quality of life, Antineoplastic Agents/therapeutic use [MeSH], Claudins/metabolism [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6448929Test; https://doi.org/10.1007/s10120-020-01153-6Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064997Test/

الإتاحة: https://doi.org/10.1007/s10120-020-01153-6Test
https://repository.publisso.de/resource/frl:6448929Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064997Test/

المؤلفون: Willner, A., Fechner, K., Agaimy, A., Haller, F., Eckstein, M., Ott, O. J., Putz, F., Gaipl, U. S., Kersting, S., Meidenbauer, N., Grützmann, R., Fietkau, R., Semrau, S.

المصدر: http://lobid.org/resources/99370674185806441Test#!, 197(12):1063-1071.

مصطلحات موضوعية: Ifosfamide, Liposarcoma, Humans [MeSH], Treatment Outcome [MeSH], Chemoradiotherapy/methods [MeSH], Leiomyosarcoma, Neoadjuvant Therapy/methods [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Feasibility Studies [MeSH], Original Article, Hyperthermia, Induced/methods [MeSH], Doxorubicine, Sarcoma/pathology [MeSH], Ifosfamide [MeSH], Sarcoma/therapy [MeSH], Chemoradiotherapy/adverse effects [MeSH], Thermotherapy

العلاقة: https://repository.publisso.de/resource/frl:6448579Test; https://doi.org/10.1007/s00066-021-01830-0Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604874Test/

الإتاحة: https://doi.org/10.1007/s00066-021-01830-0Test
https://repository.publisso.de/resource/frl:6448579Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604874Test/